ÂÜÀòÂÒÂ×

Xiang Pan is the current Associate Director and Principal Scientist at Clade Therapeutics, focusing on hiPSC Engineering for allogenic cell therapy. Prior to this role, Xiang Pan worked as a Senior Scientist at Goldfinch Bio, where they led the Human Biology Platform and optimized hiPSC derived podocyte differentiation protocol. Xiang Pan also worked as a Senior Associate Scientist at Cue Biopharma, focusing on CHO cell expression and purification for Immuno-STATs. With a background in Biochemistry and Molecular Biology, Xiang Pan has a strong research history and expertise in developing innovative protocols for in-vitro compound screening.